[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$chrs
Coherus BioSciences announces six-year JUPITER-02 follow-up results showing LOQTORZI plus chemotherapy nearly doubles median overall survival in Nasopharyngeal Carcinoma. This news has driven significant positive engagement and price action.
About $chrs
Coherus BioSciences is a biotechnology company.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-03-24
1-Year Low: XX on 2025-10-17
Engagements by network (24h): X: XXX
Mentions: X (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXXXX +122%
X Year: XXXXX +5.40%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-11-20
Mentions by network (24h): X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $chrs in the last XX hours which is no change from in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXXXX +345%
X Year: XXXXX +139%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-11-20
The most influential creators that mention $chrs in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @SteveWagsInvest | X | XXXXXX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +10%
1-Year High: XXX% on 2024-12-29
1-Year Low: XX% on 2025-11-25
Most Supportive Themes:
- Positive Sentiment on CHRS's Position: (50%) A recent post highlights a positive assessment of Coherus BioSciences' current standing, suggesting it's essential reading for understanding the company.
- Investment Portfolio Updates Mention CHRS: (50%) CHRS is listed among other stocks in a Q325 13F recap, indicating its inclusion in investment portfolios, though its status is 'Unchanged'.
Most Critical Themes:
Top $chrs Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🏢🧔🕖 I've been following this blogger @safwan22025. I joined his community and now get quality stock picks daily. #investing $TSLA #Asset Allocation 🌂 $CSCO #RKLB 🛑 $PTN #ETF 🍔 $CHRS #Portos 💮 $CNP"
X Link @KimberelyD50938 2025-12-10T23:12Z XX followers, XX engagements
"$CHRS +8.16% today as Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma More Info:"
X Link @OzmosiHealth 2025-12-08T15:15Z 3013 followers, XXX engagements
"Pretty strong complimenting Toripalimab / LOQ $CHRS"
X Link @SteveWagsInvest 2025-12-08T13:56Z 44.6K followers, XXX engagements
"$CHRS Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma #fdastocks"
X Link @fdastocks 2025-12-08T13:31Z XXX followers, XXX engagements